News

Now Open: calls for visiting Professor and PhD selections at Fiocruz

Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. There are open selections for PhDs with Experience Abroad and for Visiting professor.

Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. There are open selections for PhDs with Experience Abroad and for Visiting professor. The PhD with Experience Abroad aims to attract researchers with experience ... Read more

Fiocruz President talks about the arrival of the Covid-19 in Brazil

Nísia Trindade Lima comments on the context of the pandemic, its challenges and the institutional response to the health crisis.

In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the ... Read more

Fiocruz inaugurates a laboratory in Antarctica

Pamela Lang (AFN)

With the launch of the new Comandante Ferraz Antarctica Station on January 15, Fiocruz now relies on a permanent laboratory in the continent. Fiolab will be a biosafety laboratory prepared to respond to Brazil’s needs regarding epidemiological and public health ... Read more

Fiocruz takes part on WHO event on new coronavirus

Julia Dias (AFN)

Fiocruz takes part on a meeting of hundreds of scientists from all over the world at the headquarters of the World Health Organization (WHO), in Geneva, on February 11 and 12, to discuss how research can be used to intensify ... Read more

[In the press] Science links China and Brazil

Published originally on Ciência Hoje [CH; Science Today] - Valquíria Daher

Interview with Carlos Morel, former president of Fiocruz and general coordinator of the Center for Technological Development in Health. Read more

Fiocruz takes part on WHO event on new coronavirus

Julia Dias (AFN)

Fiocruz takes part on a meeting of hundreds of scientists from all over the world at the headquarters of the World Health Organization (WHO), in Geneva, on February 11 and 12, to discuss how research can be used to intensify ... Read more

Fiocruz builds new hospital center and invests in clinical trials with WHO

The rapid assembly unit will have 200 beds exclusive for treatment of Covid-19. The new space will hold the Solidarity clinical trial.

The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit ... Read more

Inequalities in the realm of International Health Emergencies

Dr. Deisy Ventura, professor at the Faculty of Public Health of the University of São Paulo, stated that strengthening national health systems is key to respond to any emergency

On this occasion, Dr. Ventura, talked about the crucial role of health systems to respond to emergencies and the inequalities inherent to emergency declarations issued by the International Health Regulations (IHR, 2005) system. Read more

Fiocruz takes part in WHO meeting to fight the pandemic

Leaders of more than 30 global health institutions shared their experience in the fight against Covid-19 and the creation of a safe and gradual strategy for the post-quarantine.

Julia Dias Fiocruz president, Nísia Trindade Lima, attended last Wednesday (April 1st) a meeting of global health leaders requested by the director-general of the World Health Organization, Tedros Adhanom. The goal of the meeting was to discuss the advancement of ... Read more

Fiocruz becomes part of a Coalition to accelerate research on covid-19

The initiative of more than 70 scientists and institutions of 30 countries aims to guarantee access to advances in the research to developing countries and vulnerable populations

Julia Dias Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday ... Read more

Fiocruz investigates the action of anti-retrovirals against Covid-19

A study has observed that the drug Atazanavir was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs.

A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening ... Read more

World Chagas Day is celebrated for the first time

Starting this year, April 14th will serve to give visibility in the global health agenda to the challenges faced by patients of Chagas disease

On this Tuesday, April 14th is celebrated for the first time as the World Chagas Day, after being recognized in 2019 by the World Health Organization (WHO). To mark the day that remembers the first case diagnosed in humans by ... Read more

Fiocruz is designated as reference institution in Covid-19 in the Americas for the WHO

The Laboratory for Respiratory Viruses and Measles has been formally acknowledged as reference in the continent, together with the CDC

Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more

Fiocruz launches a partnership program for actions against Covid-19

'United against Covid-19' is a channel for organizations and individuals interested in support Fiocruz initiatives to fight the pandemic

17/04/2020 Glauber Gonçalves (COC/Fiocruz), with the collaboration of Erika Farias (CCS/Fiocruz) Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This ... Read more

Fiocruz launches a partnership program for actions against Covid-19

'United against Covid-19' is a channel for organizations and individuals interested in support Fiocruz initiatives to fight the pandemic

17/04/2020 Glauber Gonçalves (COC/Fiocruz), with the collaboration of Erika Farias (CCS/Fiocruz) Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This ... Read more

Fiocruz will be producing 11 million molecular tests

The production will help to implement a massive testing strategy in Brazil, as recommended by WHO

28/04/2020 Fiocruz The Oswaldo Cruz Foundation (Fiocruz) will be producing 11 million tests for the Ministry of Health (MS) by September. The Foundation began supplying the tests on March 4. The goal of the first agreement was to produce 25,000 ... Read more

High doses of chloroquine are not indicated by CloroCovid-19

The trial is conducted by more than 70 researchers and aims to evaluate the safety and efficacy of two different doses of drugs in severe patients.

29/04/2020 Ricardo Valverde Published in the JAMA Network Open, the initial results of the CloroCovid-19 trial show that patients with severe Covid-19 should not take high doses of chloroquine. The trial, whose goal is to assess the efficacy of two ... Read more

MonitoraCovid-19 shows that deaths double every 5 days

In the United States and in Ecuador, the interval necessary for this duplication is an average of 6 days. In Italy and in Spain, 8 days.

28/04/2020 Icict/Fiocruz The number of deaths caused by Covid-19 has doubled every 5 days in Brazil, on average. In the United States and in Ecuador, countries with high dissemination rates, the interval necessary for this duplication is an average of ... Read more

Report assesses dissemination of Covid-19 among indigenous population

As the disease moves to smallest cities, a marked increase in the rate of indigenous populations at high risk is also expected.

28/04/2020 Ricardo Valverde Photo: © Wilfred Paulse A group of researchers of the Oswaldo Cruz Foundation (Fiocruz) and of the Getulio Vargas Foundation (FGV) has just released a report on the risk of Covid-19 dissemination among indigenous populations, due to ... Read more

Fiocruz produces the country's first generic drug for hepatitis B

The Institute of Drug Technology (Farmanguinhos/Fiocruz) has started the production of the first generic drug in the country to treat chronic liver infection caused by the hepatitis B virus (HBV)

20/05/2020 Tatiane Sandes (Farmanguinhos/Fiocruz) The Institute of Drug Technology (Farmanguinhos/Fiocruz) has started the production of the first generic drug in the country to treat chronic liver infection caused by the hepatitis B virus (HBV). It is the Entecavir 0.5 mg, ... Read more

Animation about Carlos Chagas gets an English version

The episode is part of the series, Ciência em Gotas (Science in Drops), an initiative of the Casa de Oswaldo Cruz (COC/Fiocruz), which features the journey of Brazilian scientists with relevant activities in the field of public health and the environment.

20/05/2020 COC/Fiocruz The animation Carlos Chagas, which features the paths taken by the scientist until the discovery of Chagas disease, has just got a version in English. Available on the Internet, the episode is part of the series, Ciência em ... Read more

Covid-19: Fiocruz Hospital Center starts operating

Located in Manguinhos, headquarters of the Foundation in Rio de Janeiro, the Hospital Center for Pandemic Covid-19 - National Institute of Infectious Diseases Evandro Chagas (INI / Fiocruz) started receiving, on May 19, the first patients.

25/05/2020 Aline Camara (CCS/Fiocruz) and Antonio Fuchs (INI/Fiocruz) Compartilhar: In another step of its actions to combat the pandemic of the new coronavirus, the Oswaldo Cruz Foundation (Fiocruz) built in less than two months a hospital unit for severe patients ... Read more

Covid-19: 7.8 million Brazilians are 4 hours away from adequate healthcare

This is one of the main conclusions of the most recent analysis by the Institute of Scientific and Technological Communication and Information in Health (Icict), of Fiocruz.

25/05/2020 Icict/Fiocruz Compartilhar: More than 7.8 million Brazilians are at least four hours away from a town where high-complexity healthcare is available, such as an intensive care unit (ICU), suitable equipment and staff specialized in severe and acute respiratory diseases ... Read more

New Zika Cases in Brazil Overshadowed by Covid-19

579 Cases in 3 Months Show Need for Reproductive Rights, Sanitation

Ximena Casas Researcher, Women's Rights Division As Covid-19 dominates headlines, the Zika virus silently continues to put women and children at grave risk in Brazil, and the country has not taken nearly enough steps to combat the mosquito-borne disease or ... Read more

[In the press] Rio de Janeiro’s temple to health sciences!

In line with the history and spirit of Dr Oswaldo Cruz, the foundation that carries his name and celebrates its 120th anniversary continues to provide Brazil and the world with innovative and high-quality health services thus fulfilling the bold vision of

04/06/2020 Published originally in the Financial Express. By André Aranha Corrêa do Lago & Pedro Ivo Ferraz da Silva In line with the history and spirit of Dr Oswaldo Cruz, the foundation that carries his name and celebrates its 120th ... Read more

‘Fiocruz against Covid-19’ benefits vulnerable populations

The Fiocruz against Covid-19 will benefit, all over the country, 145 projects that focus on vulnerable populations, such as quilombos (rural afro-brazilian settlements), indigenous peoples, riverside populations and favela dwellers.

01/06/2020 Márcia Corrêa e Castro (Canal Saúde) e Regina Castro (CCS/Fiocruz) The Fiocruz against Covid-19 will benefit, all over the country, 145 projects that focus on vulnerable populations, such as quilombos (rural afro-brazilian settlements), indigenous peoples, riverside populations and favela ... Read more

Interview: supporting breastfeeding mothers

João Aprígio Guerra de Almeida champions social mobilization to promote the use of donated breast milk for infants who cannot be breastfed directly by their mothers.

02/06/2020 Andréia Azevedo Soares (WHO) João Aprígio Guerra de Almeida champions social mobilization to promote the use of donated breast milk for infants who cannot be breastfed directly by their mothers. The driving force behind the Rede Brasileira de Bancos ... Read more

For ECLAC, OTSS Observatory is “a transforming investment”

Created in 2009 based on an alliance between Fiocruz and the Traditional Communities Forum of Angra dos Reis, Paraty and Ubatuba), the Observatory of Sustainable and Healthy Territories of the Bocaina (OTSS) has been considered by ECLAC

02/06/2020 Comunicação OTSS Created in 2009 based on an alliance between the Oswaldo Cruz Foundation (Fiocruz) and the Fórum de Comunidades Tradicionais de Angra dos Reis, Paraty e Ubatuba (FCT; Traditional Communities Forum of Angra dos Reis, Paraty and Ubatuba), ... Read more

Fiocruz develops a protocol to sequence the new coronavirus

Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2.

02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more

Brazilian elderly population lost income during the pandemic

During the new coronavirus epidemic, 36% of the Brazilian elderly who still work have been left without any income, or have experienced significant reduction in their income.

10/06/2020 Icict-Fiocruz During the new coronavirus epidemic, 36% of the Brazilian elderly who still work have been left without any income, or have experienced significant reduction in their income. Among those without a formal job, this number is even higher: ... Read more

Covid-19: Fiocruz will begin pre-clinical trials for a vaccine

The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2).

12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more

Covid-19 affects Brazilians habits and work

During the first weeks of social distancing due to the Covid-19 epidemic, a great part of the Brazilian population reported mood issues

09/06/2020 Icict/Fiocruz During the first weeks of social distancing due to the Covid-19 epidemic, a great part of the Brazilian population reported mood issues. Forty percent felt sad or depressed and 54% felt anxious or nervous frequently. The percentages were ... Read more

Covid-19: Fiocruz program will send donations to the amazon

Almost R$ 6 million (around US$1,2 million) in tests for Covid-19, personal protective equipment (PPE) and test devices will be donated to state of Amazonas to face the new coronavirus.

18/06/2020 Marlúcia Seixas (Fiocruz Amazônia) Almost R$ 6 million (around US$1,2 million) in tests for Covid-19, personal protective equipment (PPE) and test devices will be donated to state of Amazonas to face the new coronavirus. The material will be transferred ... Read more

Fiocruz concludes Atazanavir technological absorption

The Institute of Drug Technology (Farmanguinhos/Fiocruz) concluded, in early June, the manufacture of Atazanavir pilot batches, an antiretroviral used to treat thousands of people living with HIV/AIDS.

18/06/2020 Alexandre Matos (Farmanguinhos/Fiocruz) Compartilhar: The Institute of Drug Technology (Farmanguinhos/Fiocruz) concluded, in early June, the manufacture of Atazanavir pilot batches, an antiretroviral used to treat thousands of people living with HIV/AIDS. Public production was made possible by a technology ... Read more

Nova epidemia? estudo identifica circulação de nova linhagem da Zika no Brasil

Mesmo em meio a uma pandemia que tem afetado o cotidiano de todos, a população brasileira ainda convive com as consequências da última emergência nacional de saúde pública: a da Zika, que desde 2015 levou ao nascimento de 3.534 bebês com Síndrome Congênit

Escrito por Raíza Tourinho em 19 de junho de 2020 Mesmo em meio a uma pandemia que tem afetado o cotidiano de todos, a população brasileira ainda convive com as consequências da última emergência nacional de saúde pública: a da ... Read more

Covid-19: Fiocruz will sign an agreement to produce vaccines by the University of Oxford

The Oswaldo Cruz Foundation (Fiocruz) will sign an agreement with pharmaceutical company AstraZeneca for the acquisition of batches and transference of technology regarding the Covid-19 vaccine developed by the University of Oxford.

30/06/2020 Fiocruz The Oswaldo Cruz Foundation (Fiocruz) will sign an agreement with pharmaceutical company AstraZeneca for the acquisition of batches and transference of technology regarding the Covid-19 vaccine developed by the University of Oxford. The agreement will be the result ... Read more

Drugs against hepatitis C inhibit the replication of the new coronavirus

A study led by the Oswaldo Cruz Foundation (Fiocruz) has observed that drugs currently used to treat hepatitis C inhibit the replication of the new coronavirus (SARS-CoV-2) in experiments made with cells.

29/06/2020 Maíra Menezes (IOC/Fiocruz) A study led by the Oswaldo Cruz Foundation (Fiocruz) has observed that drugs currently used to treat hepatitis C inhibit the replication of the new coronavirus (SARS-CoV-2) in experiments made with cells. The experiments have identified, ... Read more

Article discusses how Covid-19 impacts mental health

Although respiratory symptoms are the best-known face of Covid-19, post-traumatic stress (PTSD), depression, and anxiety have also been described in patients with the disease.

29/06/2020 Maíra Menezes (IOC/Fiocruz) Although respiratory symptoms are the best-known face of Covid-19, post-traumatic stress (PTSD), depression, and anxiety have also been described in patients with the disease. In an article published in Frontiers in Immunology, researchers of the Oswaldo ... Read more

Study identifies a new strain of zika virus circulating in Brazil

Even in the midst of a pandemic that has affected the everyday life of virtually everyone, Brazilians are still living with the consequences of the last national public health emergency: the zika virus, which has led to the birth of 3,534 babies with cong

26/06/2020 Raiza Tourinho (Fiocruz Bahia) Even in the midst of a pandemic that has affected the everyday life of virtually everyone, Brazilians are still living with the consequences of the last national public health emergency: the zika virus, which has ... Read more

Fiocruz will coordinate a Unitaid project on Chagas disease

The Chagas Consortium of the Oswaldo Cruz Foundation (Fiocruz) has been selected in the first phase of the Unitaid call that aims to eliminate congenital transmisson of Chagas disease in endemic countries in Latin America

26/06/2020 Antonio Fuchs and Juana Portugal (INI/Fiocruz) The Chagas Consortium of the Oswaldo Cruz Foundation (Fiocruz) has been selected in the first phase of the Unitaid call that aims to eliminate congenital transmisson of Chagas disease in endemic countries in ... Read more